×
Comparison of Venlafaxine Alone Versus Venlafaxine Plus Bright Light Therapy Combination for Severe Major Depressive Disorder PDF
$ 40.00
Comparison of Venlafaxine Alone Versus Venlafaxine Plus Bright Light Therapy Combination for Severe Major Depressive Disorder PDF quantity
$ 40.00
×
The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): Design and Baseline Subject Characteristics PDF
$ 40.00
The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): Design and Baseline Subject Characteristics PDF quantity
$ 40.00
×
Correlates of Overweight and Obesity in 644 Patients With Bipolar Disorder PDF
$ 40.00
Correlates of Overweight and Obesity in 644 Patients With Bipolar Disorder PDF quantity
$ 40.00
×
A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease PDF
$ 40.00
A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease PDF quantity
$ 40.00
×
A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia PDF
$ 40.00
A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia PDF quantity
$ 40.00
×
Clinical Effects of Buspirone in Social Phobia: A Double-Blind Placebo-Controlled Study PDF
$ 40.00
Clinical Effects of Buspirone in Social Phobia: A Double-Blind Placebo-Controlled Study PDF quantity
$ 40.00
×
Hypersensitivity Psychosis and Lack of Compliance in the Penitentiary Environment PDF
$ 40.00
Hypersensitivity Psychosis and Lack of Compliance in the Penitentiary Environment PDF quantity
$ 40.00
×
A Double-Blind, Randomized Study Comparing the Efficacy and Safety of Sertindole and Risperidone in Patients With Treatment-Resistant Schizophrenia PDF
$ 40.00
A Double-Blind, Randomized Study Comparing the Efficacy and Safety of Sertindole and Risperidone in Patients With Treatment-Resistant Schizophrenia PDF quantity
$ 40.00
×
Interactions of Borderline Personality Disorder and Mood Disorders Over 10 Years PDF
$ 40.00
Interactions of Borderline Personality Disorder and Mood Disorders Over 10 Years PDF quantity
$ 40.00
×
Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study PDF
$ 40.00
Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study PDF quantity
$ 40.00
×
A Model of the Economic Impact of a Bipolar Disorder Screening Program in Primary Care PDF
$ 40.00
A Model of the Economic Impact of a Bipolar Disorder Screening Program in Primary Care PDF quantity
$ 40.00
×
Incidence of, Risk Factors for, and Changes Over Time in Treatment-Resistant Depression in Denmark: A Register-Based Cohort Study PDF
$ 40.00
Incidence of, Risk Factors for, and Changes Over Time in Treatment-Resistant Depression in Denmark: A Register-Based Cohort Study PDF quantity
$ 40.00
×
Comparison of Quetiapine and Risperidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Flexible-Dose, 8-Week Study PDF
$ 40.00
Comparison of Quetiapine and Risperidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Flexible-Dose, 8-Week Study PDF quantity
$ 40.00
×
Antidepressant Exposure May Protect Against Decrement in Frontal Gray Matter Volumes in Geriatric Depression PDF
$ 40.00
Antidepressant Exposure May Protect Against Decrement in Frontal Gray Matter Volumes in Geriatric Depression PDF quantity
$ 40.00
×
Sexual Dysfunction in Male Subjects Receiving Trifluoperazine, Risperidone, or Olanzapine: Rates Vary With Assessment Questionnaire PDF
$ 40.00
Sexual Dysfunction in Male Subjects Receiving Trifluoperazine, Risperidone, or Olanzapine: Rates Vary With Assessment Questionnaire PDF quantity
$ 40.00
×
Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine PDF
$ 40.00
Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine PDF quantity
$ 40.00
×
Inpatient Detoxification From a Synthetic Cannabinoid and Control of Postdetoxification Cravings With Naltrexone PDF
$ 40.00
Inpatient Detoxification From a Synthetic Cannabinoid and Control of Postdetoxification Cravings With Naltrexone PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart